Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Coagulopathy | postmarketing | x | |
| Thrombocytopenia | postmarketing | x | |
| Prothrombin level increased | postmarketing | x | |
| Shutdown renal | postmarketing | x | |
| Activated partial thromboplastin time prolonged | postmarketing | x | |
| Serum ferritin increased | postmarketing | x | |
| Iron overload | postmarketing | x | |
| Body temperature increased | x | ||
| Leukocytosis | x | ||
| Phlebitis | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |